IS7832A - Virkjanlegur bindill fyrir a1ß1-integrín og notkun - Google Patents

Virkjanlegur bindill fyrir a1ß1-integrín og notkun

Info

Publication number
IS7832A
IS7832A IS7832A IS7832A IS7832A IS 7832 A IS7832 A IS 7832A IS 7832 A IS7832 A IS 7832A IS 7832 A IS7832 A IS 7832A IS 7832 A IS7832 A IS 7832A
Authority
IS
Iceland
Prior art keywords
integrin
active ligand
ligand
active
Prior art date
Application number
IS7832A
Other languages
English (en)
Inventor
Cosgrove Dominic
Original Assignee
Boys Town National Research Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boys Town National Research Hospital filed Critical Boys Town National Research Hospital
Publication of IS7832A publication Critical patent/IS7832A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IS7832A 2002-11-01 2005-04-29 Virkjanlegur bindill fyrir a1ß1-integrín og notkun IS7832A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42329702P 2002-11-01 2002-11-01
PCT/US2003/034818 WO2004041846A2 (en) 2002-11-01 2003-10-31 INDUCIBLE LIGAND FOR α1β1 INTEGRIN AND USES

Publications (1)

Publication Number Publication Date
IS7832A true IS7832A (is) 2005-04-29

Family

ID=32312635

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7832A IS7832A (is) 2002-11-01 2005-04-29 Virkjanlegur bindill fyrir a1ß1-integrín og notkun

Country Status (14)

Country Link
US (2) US7348002B2 (is)
EP (1) EP1562632B1 (is)
JP (1) JP2006516024A (is)
KR (1) KR20050084921A (is)
CN (1) CN1826137A (is)
AU (1) AU2003287435A1 (is)
BR (1) BR0315054A (is)
CA (1) CA2504125A1 (is)
EA (1) EA200500576A1 (is)
IS (1) IS7832A (is)
MX (1) MXPA05004563A (is)
NO (1) NO20052495L (is)
PL (1) PL376714A1 (is)
WO (1) WO2004041846A2 (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2504125A1 (en) * 2002-11-01 2004-05-21 Boys Town National Research Hospital Inducible ligand for .alpha.1.beta.1 integrin and uses
ES2304069B1 (es) * 2003-08-22 2009-08-12 Proyecto De Biomedicina Cima, S.L. Peptidos con capacidad de unirse al factor transformante de crecimiento beta 1 (tgf-b1).
EP1802331A2 (en) * 2004-09-08 2007-07-04 Boys Town National Research Hospital Treatment of glomerular basement membrane disease involving matrix metalloproteinase-12
US7718765B2 (en) * 2005-11-16 2010-05-18 The University Of Tennessee Research Foundation Methods of treating fibrosing diseases by induction of immune tolerance
MX2010003019A (es) 2007-09-19 2010-04-30 Pluristem Ltd Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
US9719981B2 (en) 2012-08-17 2017-08-01 Father Flanagan's Boys' Home RAC1 inhibitors for the treatment of alport glomerular disease
AU2020296105A1 (en) 2019-06-21 2022-02-03 Father Flanagan's Boys' Home Doing Business As Boys Town National Research Hospital Neutralizing antibodies to human endothelin
CN114887034B (zh) * 2022-07-14 2022-10-28 中山莱博瑞辰生物医药有限公司 LLP2A-Ale在制备用于治疗和/或预防外周血淋巴细胞减少症的药物中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391481A (en) * 1990-08-31 1995-02-21 The Trustees Of Columbia University Antibody which is directed against and inhibits collagen binding to a VLA-1 epitope and uses thereof
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US6492325B1 (en) * 1998-05-22 2002-12-10 Boys Town National Research Hospital Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease
HUP0202048A3 (en) * 1998-05-22 2006-11-28 Boys Town Nat Res Hospital Oma Use of alpha1betha1 integrin receptor inhibitors and tgf-betha1 inhibitors in the treatment of kidney disease
EP1181054A1 (en) * 1999-06-01 2002-02-27 Biogen, Inc. A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
CA2504125A1 (en) * 2002-11-01 2004-05-21 Boys Town National Research Hospital Inducible ligand for .alpha.1.beta.1 integrin and uses

Also Published As

Publication number Publication date
NO20052495D0 (no) 2005-05-24
US20040253241A1 (en) 2004-12-16
AU2003287435A1 (en) 2004-06-07
MXPA05004563A (es) 2005-07-26
CN1826137A (zh) 2006-08-30
PL376714A1 (pl) 2006-01-09
EP1562632A4 (en) 2007-01-17
JP2006516024A (ja) 2006-06-15
WO2004041846A3 (en) 2005-04-28
CA2504125A1 (en) 2004-05-21
US7348002B2 (en) 2008-03-25
AU2003287435A2 (en) 2004-06-07
KR20050084921A (ko) 2005-08-29
WO2004041846A2 (en) 2004-05-21
EP1562632A2 (en) 2005-08-17
US7662382B2 (en) 2010-02-16
EA200500576A1 (ru) 2006-02-24
BR0315054A (pt) 2005-08-16
US20080227121A1 (en) 2008-09-18
EP1562632B1 (en) 2012-12-05
NO20052495L (no) 2005-07-25

Similar Documents

Publication Publication Date Title
EP1485754A4 (en) VITRINE AND MERCHANDISE EXPOSURE SYSTEM
NO2017017I1 (no) umeklinidium og vilanterol
DE602004019294D1 (de) Tetrahydronaphthalin- und harnstoffderivate
NO20021341D0 (no) Autentisering og tilgangsstyring
IS8054A (is) Kannabinóíð viðtaka bindlar og notkun þeirra
IS8137A (is) Kannabinóíð viðtaka bindlar og notkun þeirra
NO20053974D0 (no) Tienopyrimidinforbindelser og anvendelse derav.
DE60331092D1 (de) Hydro- und oleophobiermittel
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
DE60332126D1 (de) Tragbares funkgerät
DE602004018027D1 (de) Tragbare vorrichtungen und abdeckungen für tragbare vorrichtungen
DK1667668T3 (da) Alfabeta3 og altabeta6-integrinantagonister som antifibrotiske midler
DE602005003819D1 (de) Perfluoroelastomer- und fluoroplastikgemische
PT1558595E (pt) Piperazinil e diazepanil benzamidas e benzotioamidas
ATE423117T1 (de) Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone
FI20040094L (fi) Sisäänrakennettu antenni ja sen sisältävä matkaviestin
IS7832A (is) Virkjanlegur bindill fyrir a1ß1-integrín og notkun
DE60319216D1 (de) Mobile endgeräteeinrichtung
NO20026097D0 (no) Anordning for kombinert adgang og input
EP1786431A4 (en) IMPROVED PHOTOSENSITIZER FORMULATIONS AND THEIR USE
FI20021962A7 (fi) Katalysaattoriyksikkö ja -järjestely
EP1660088A4 (en) PYRIDOMORPHINANE, PYRIDAZINOMORPHINANE AND ITS USE
DK1478300T3 (da) Kofferdam-afdækningsmiddel og strimmelformet fastgöringsmiddel dertil
NO20053898D0 (no) Use and proceeding at footballshoes
ITCR20020004V0 (it) Portamonete